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1. Introduction  
Due to new information about the pathophysiology and biomechanics of degenerative 
lumbar spine disease, the surgical treatment of this disease has undergone a significant 
increase over the past forty years. Novel diagnostic approaches and the development of new 
materials provided the impetus to produce new types of instrumentation, and these 
instruments have led to the modernization of interbody fusion including PLIF, TLIF and 
ALIF methods. These interventions are currently performed in either an open mini-invasive 
or endoscopic manner. The open interventions are indicated in cases where the spinal canal 
stenosis is caused by severe degenerative lesions affecting the motion of intervertebral discs, 
joints, ligaments, or vertebral arch. Despite the development of other surgical techniques 
(e.g., functional disc substitutes, dynamic stabilization), the posterior interbody fusion 
represents a powerful approach in the surgical treatment of degenerative stenosis of the 
spinal canal.  
The PLIF method was first applied in the 1940s by Briggs and Milligan who inserted 
crushed bone grafts into the intervertebral space, and the bone grafts insertion technique 
was further developed by Cloward (Cloward, 1953). Due to complications associated with 
autografts (i.e., pain at the sampling site, procedure prolongation, etc.), the PLIF surgical 
technique was improved in the 1980s, and new implants constructed of various materials 
were developed (Bienik and Swiecki, 1991; Brantigan et al, 1994; Khoo et al, 2002; Šrámek et 
al, 2010). Likewise, novel diagnostic tools have been developed including MRI, 3D CT, 
SPECT-CT (Crock, 1976, Modic et al, 1988; Blumenthal et al, 1988), and new materials (e.g., 
ceramic, titanium, PEEK) have yielded new types of implants leading to the modernization 
of the interbody fusion via PLIF techniques (Alexander et al, 2002; Bessho et al, 1997; Brayan 
et al, 2002; Ciappetta et al, 1997; Kokubo, 1990; Yamamuro, 1995; Hashimoto et al, 2002; 
Thalgott et al, 2002; Sandhu, 2003). Currently, the majority of implants for PLIF consist of 
two separate components, including the solid cage shape and osseoconductive material (i.e., 
TCP, BMP) that ensures osteoblastic activity and the interbody fusion formation. To date, no 
material with both suitable mechanic properties and high grade bioactivity is currently 
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available. For instance, solid materials (e.g., medical steel, titanium, PEEK) lack bioactivity 
that is able to support the osseoconduction (Carlson et al, 1988; Williams and McNamara, 
1987; Zdeblick and Philips, 2003). Likewise, bioactive or resorbable materials (e.g., glass-
ceramic, hydroxyapatite, polysacharides) do not meet the mechanical requirements for 
fusion implants of intervertebral discs (Hench el al, 1971; Filip et al, 1996; Sobale et al, 1990; 
McAfee, 1986).  
Currently, the majority of implants consist of cages that form various shapes. The perimeter 
is constructed from a solid material that ensures the structural strength. The centre of the 
cage is hollow and is filled by bone grafts or osseoconductive material (e.g. bi- or tri-calcium 
phosphate) to promote bone fusion in this part of the implant. The optimal implant for an 
interbody fusion should imitate the properties of the bone tissue by combining sufficient 
mechanical strength as well as bioactive surface. Therefore, the mechanical strength and the 
shape of the implant should ensure the primary stability of the segment of the lumbar spine 
following the operation. Furthermore, the bioactive surface should allow stimulation of 
osteoblast proliferation at the interface of the implant and bone, and should promote 
activation of their migration along the implant surface. The bioactive surface should also act 
as a conductor for osteoblast migration to the fixed vertebral bodies to form the fusion. This 
quality would prevent the requirement for additional filling of the implant by 
osseoconductive material. The aim of our work was to create an implant with optimal 
strength and bioactivity in an attempt to replace the use of autografts and two-compartment 
implants for PLIF.  
2. Research  
2.1 Advantages and disadvantages of PLIF surgical technique using autografts 
When the conservative treatment fails, patients from categories LS syndrome and FBS 
syndrome (Failed Back Surgery syndrome) are often referred to surgical management via 
posterior interbody fusion (Benzel et al, 2003; Cloward, 1953; Crock, 1976; Daniaux, 1986; 
Dove, 1990; Gurr et al, 1999; Cho et al, 2002). The indication for this surgery is based on 
neurological finding. In general, the patient predominantly either suffers from back pain 
associated with progression of root lesion in a lower extremity or with neurogenic 
claudications in the lower limbs, and shows no reaction to the full conservative therapy 
algorhytm (Anderson, 2000; Brinnckman et al, 1989; Brodke et al, 1997; Cloward, 1953, 
Hrabálek et al, 2009; Paleček et al, 1994; Fischgrund et al, 1997). Furthermore, the disease is 
supported by graphic images of compression of the neural structures caused by 
degenerative lesions (Knudson, 1944; Crock, 1978; Modick et al, 1983; Sonntag and 
Theodore, 2000). The desired clinical effect can be achieved by the decompression of neural 
structures together with spondylodesis of the affected spine segment using PLIF (Steffee, 
1988; Hashimoto el al, 2002; Dick, 1987; Wang et al, 2005). When surgical treatment is 
necessary, no acceptable scientific long-term evidence of efficacy exists for any type of 
surgical treatment of the degenerative lumbar spine disease (Brodke et al, 1997; Benzel, 2003; 
Sonntag and Theodore, 2000; Paleček et al, 1994).  
We performed PLIF using autografts that were developed in the 1980s. An autograft (mostly 
iliac crest bone grafts) stripped of connective tissue was inserted under compression into the 
intervertebral space. The best stability was achieved by transpedicular fixation of the 
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operated segment necessary for osteointegration of the grafts via their remodeling and PLIF 
formation (Bauer and Muschler, 2000). The advantage of a recently collected autolog bone 
graft has been the presence of live bone cells with mineralized extracellular matrix. The 
biological activity, structure and proteins of bone morphogenesis are important 
prerequisites of the fusion. In addition, clinical experiences from the first half of the 20th 
century have proved better surgical outcomes with autolog grafts in comparison to simple 
decompression (Cloward, 1953; Dawson et al, 1981; Dick, 1987; Carlson et al, 1988). Autolog 
grafts in this form have been the gold standard for PLIF in the majority of spondylosurgical 
clinics through the end of the 20th century. Despite improving surgical outcomes with a 
growing number of operated patients, new complications still exist regarding this otherwise 
successful surgical technique (Kurz et al, 1989).  
The most common complications associated with this surgery include problems with bone 
graft sampling in that limitations are present in bone size and structure that may be safely 
collected from a live patient in cases of extensive intervention. Furthermore, patients can 
suffer from unpleasant reactions including debilitating postoperative pain, infection, 
seroma, cosmetic defects, nerve injury, hip fractures, vessel injury and blood loss. These 
adverse reactions can occur in 10 to 39% of cases (Arrington et al, 1996; Banwart el al, 1994; 
Banwart et al, 1995). Therefore, these reactions and other problems have led to search for 
artificial materials for PLIF. The optimal material for PLIF substituting bone grafts should 
ideally have the following characteristics. First, the material should show solid structural 
support (load resistance immediately after implantation). Second, the material should 
display osseoconductivity and bioactivity or the ability to bind with a bone, fusion support 
without any other additional material (e.g., bone, BCP etc.). Third, the material should 
provide the possibility for a radiographical assessment of the bone fusion process. Finally, 
the material should show biomechanic properties (elasticity modulus similar to bone). 
2.2 Development of a new implant for PLIF  
As described in chapter 2.1, we considered using an implant made from a synthetic material 
for PLIF in the early 1990s to eliminate the disadvantages of autografts (Madawi et al, 1996). 
The most available implants were constructed of medical steel (Bagby, 1988). However, 
these implants did not meet our notion of sufficient strength accompanied by bioactivity. 
Spondylosurgeons in Charkov (Professor Gruntovskij) have successfully used corundum 
implants in combination with hydroxyapatite for PLIF in the surgical treatment of 
degenerative lumbar spine disease in the 1980s. According to results of this clinic, the 
success of this implant resulted from its prism shape with projections firmly anchored in the 
intervertebral space that helped the implant to fixate the segment with or without 
transpedicular fixation following operation. Due to its bioinertion, hydroxyapatite was 
added, and this soft material was placed around the corundum (Rowlings, 1993; 
Gogolewski et al, 1993). Therefore, this implant stimulated formation of osteoblasts, and 
served as a conductor for their migration between adjacent surfaces of adjoining vertebral 
bodies. In the early 1990s, another type of prosthesis produced from bioactive glass-ceramic 
was developed by Electric Nippon Glass, and was used by Japanese orthopedists for PLIF 
(Yamamuro, 1995, Kokubo, 1990). While transpedicular fixation was added to PLIF due to 
its fragility, the bioactivity of the implant surface allowed fusion due to migration of bone 
cells along its surface  without addition of any supporting material (e.g., bone, 
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hydroxyapatite) (Sobale, 1990; Yamamuro, 1995). Based on these experiences, we began 
searching for a material for PLIF implant that would combine the advantages of both the 
shape and the strength of corundum and the bioactivity of glass-ceramic used in the early 
1990s. Thereby, the combination of these two properties would allow strong anchoring of 
this material in the intervertebral space, the restoration of anatomy in the operated segment, 
the stabilization of unstable segment, and the formation of interbody fusion associated with 
osseoconductive properties without addition of another material and without the risk of 
migration. 
2.3 Experimental development of glass-ceramic implant (BAS-O)  
Unlike bioinert or biotolerant materials, bioactive glass-ceramic material BAS-O, forms a 
strong chemical bond with live bone tissue (Fatley et al, 1979; Urban, 1992). Material BAS-O 
is prepared by progressive steps, such as sintering, controlled crystallization and others. The 
controlled crystallization allows control of processes that determine the bioactive ability of 
the final material including material transformation, the control of chemical structure, and 
the structure of the glass phase (Strnad, 1992). The ability of this material to form a strong 
bond with bone tissue results from the formation of an apatite layer on the material surface 
resulting in the connection of the bioactive material with body fluid. Crystallographic 
chemical characteristic of apatite released on the material surface is similar to the organic 
part of the bone tissue. Thereby, the stability of the operated segment without 
micromovements and the tight contact of the material without microgaps are necessary for 
perfect chemical bond BAS-O / live tissue. Otherwise, a risk of connective tissue penetration 
exists that can prevent the chemical bond on the bone / implant interface (Kokubo, 1990; 
Urban, 1992). 
The most important finding for the planned use of the lumbar implant necessitated that the 
biochemical and mechanical properties of the glass-ceramic BAS-O mimic the cortical bone 
tissue. According to the Young model, the shape of their implant exceeded twice the 
strength of the vertical load, and was close to its flexural strength. Therefore, we based our 
implant shape on our previous experiences and according to the models that we observed 
during our study visits. Together with size and shape development, we also created 
application instrumentation used for the intervertebral space as well as the operation 
procedure. At this time, the fragility of the ceramic in the contact with steel represented our 
only disadvantage in that this fragility could cause problems with insertion using metal 
application instrumentation. The application instrumentation was coated by Teflon in order 
to prevent damage to the implant. A rectangular prism-shaped implant (25 mm long, 8 mm 
high and 10 mm wide) was progressively developed after repeated experiments with 
cadavers from 1991 to 1993 (Filip et al, 1995). “Winglets” have been placed on the opposite 
sides of the prism (Figure 1).  
The winglets cut into the adjacent vertebral bodies after its rotation by 90 degrees, and the 
implant was firmly attached within the space without a risk of migration into the spinal 
canal. Due to its bioactivity, the implant should stimulate migration of bone cells along its 
surface to form interbody fusion. The application technique for the glass-ceramic implant 
was the same as with other implants for PLIF. During experimental application in cadavers, 
the implants were well-anchored in the vertebral bodies without compression of dural sac in 
the spinal canal, and this placement was confirmed by imaging techniques (X-ray and CT). 
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We also planned to apply such PLIF methods alone in both low-grade instabilities and to 
add transpedicular fixation in high-grade instabilities. 
 
 
Fig. 1. Outline of the implant and its position in the interbody space (1992). 
The implant was inserted using a specially developed instrumentation into the interbody 
space (Figure 2).  
  
Fig. 2. Glass-ceramic implant plus application fork (1992). 
2.4 Implant made of material BAS-0 in clinical practice 
Implant BAS-O was registered by the Ministry of Health of the Czech Republic with 
registration number 89/492/98-IIB in 1992. After registration of the implant and based on 
experimental results, we introduced the implant into clinical practice in 1994. Based on the 
advantages from the experimental studies (e.g., stability in the operated space, restoration of 
anatomy, elimination of the risk of bone grafts sampling, etc.), we expected that these results 
would be confirmed. From 1994 to 1999, we used this technique in 65 patients observing the 
indication criteria and the surgical procedure described in the previous chapters. We 
assessed clinic and graphic postoperative findings in 25 patients out of this population 
during follow-ups conducted three, six, and twelve months after the intervention. The 
average age of the patients was 52 years. In 22 patients, the operation represented the first 
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on the spinal segment affected by degenerative instability of various types. We applied the 
implant BAS-O according to the experimental study. Additionally, PLIF was performed 
using a pair of implants by the stand alone technique in ten patients (Figure 3), and PLIF 
was conducted using one or two implants with additional transpedicular fixation by various 
companies in fifteen patients (Synthes, Stryker etc.).  
 
Fig. 3. Fixation of L4/5 instability using a pair of glass-ceramic implants by stand alone 
technique (1995). 
We assessed our results three, six and twelve months after the operation using the ODI 
score (Oswestry Disability Index; see Table 1). The Oswestry Disability Index (ODI) has 
become one of the principal condition-specific outcome measures used in the 
management of spinal disorders. We also used imaging techniques that were available at 
the time (i.e., X-ray, CT, rarely MRI), and we assessed the change of the implant position 
in the operated space (i.e., damage, dislocation) using the postoperative imaging 
techniques (X-ray; see Table 2). 
ODI score 
of our population  
[%] 
Mean 
[n] 25 
Primary 
instability  
[n] 8 
Degenerative 
listhesis grade  
I–II [n] 11 
Isthmic listhesis 
up to grade II  
[n] 6 
Before operation 60 55 67 58 
3 months after 
operation 
39 36 44 38 
6 months after 
operation 
40 39 42 38 
12 months after 
operation 
42 40 46 41 
     
Table 1. Clinical assessment according to ODI score. 
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BAS-O implant position on X-ray 
Assessment 
Month 3 
Assessment 
Month 6 
Assessment 
Month 12 
No damage, no migration 25 23 20 
Damage, no migration 2 3 5 (20%) 
Table 2. Assessment of position change using X-ray. 
Our results indicated that we achieved a mean improvement of I grade in the 
aforementioned population according to ODI assessment during twelve months [60% 
(severe invalidity) and 42% (moderate invalidity) with mild progression in long-term; 38% 
at month three and 42% at month twelve]. Using X-ray, we diagnosed implant damage 
without fragment(s) migration towards the spinal canal or in the prevertebral direction in 
five patients (20%) after twelve months. Initially, we utilized the sole interbody fixation 
(stand alone technique) mainly in patients with low grade instability. We found that the 
clinical condition stabilized in these patients, and the postoperative imaging investigation 
showed good fixation of the operated segment without prosthetic damage and with 
adequate postoperative changes around the nerve structures (Figure 4). 
 
Fig. 4. MRI performed three years after operation of segment L4/5 using a pair of glass-
ceramic implants (1998). 
In case of 1st or 2nd grade translation as previously defined by Meyerding, we added 
posterior transpedicular fixation of the whole segment to the implant application. The 
assessments of the population showed advantages and disadvantages associated with the 
glass-ceramic implant. For example, the operation time was shortened, and firm anchoring 
in the interbody space was confirmed due to the shape and elimination of risk associated 
with bone graft sampling. However, the limiting factor for the universal use, in particular 
for application stand alone technique, was the mechanical resistance to bending at the 
ultimate load as well as the probable discongruence of the implant and the bone bed, 
especially related to shorter implants (under 10 mm). This finding was reflected by implant 
damage on X-ray in the clinical practice (see Table 2). Due to the relatively good results 
previously observed (Filip et al, 1996), we extended the stand alone technique to higher 
grades of translation. However, the lower mechanical resistance of the glass-ceramic to 
bending was observed, and damage of the implant was detected several months after the 
operation. This problem affected five patients following operation using this technique 
during twelve months. Despite implant damage, no migration towards the spinal canal or 
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across vertebral bodies occurred resulting from the construction with retention winglets and 
the chemical bond (Figure 5). 
 
Fig. 5. Slide progression at L4/5 during overload of glass-ceramic implants in 2nd grade 
instability according to Meyerding.  
We also added transpedicular fixation of the affected segment in case a patient experienced 
clinical impairment(s) due to implant damage and instability progression. We did not 
observe implant damage in the fixed segments in this study; however, we stopped using the 
stand alone technique with the glass-ceramic implant for PLIF after this experience. 
Unfortunately, we failed to directly demonstrate osseoconductive properties of the glass-
ceramic implant BAS-0 for PLIF that was associated with fusion of the adjacent vertebral 
bodies by migrating bone tissue along the glass-ceramic body from 1994 to 1999.  
2.5 Experimental development of bioactive titanium in forms by LASAK 
The LASAK Company developed bioactive titanium with original surface modification at 
the end of the 1990s. Due to the limitations of the glass-ceramic implant mentioned above, 
we have been developing a new type of implant combining bioactive properties and higher 
mechanical resistance in cooperation with LASAK Company since 1998. Characteristics of 
this material (higher strength, bioactivity) have provided optimal implant characteristics for 
PLIF (Yan, 1997; Strnad, 2010). The material used for this implant is technically pure 
titanium (grade 3) which is dedicated for surgical implants (Regulation ISO 5832-2:1993(E): 
Implants for surgery, ISO 5835-2). To ensure bioactivity of this material, the implant surface 
is chemically modified by LASAK technology (Adjudication on Permission to Use a Medical 
Device No. 82/125/00-IIB by State Institute for Drugs Control of the Ministry of Health of 
the Czech Republic). Mechanical properties of this material are identical to pure titanium, 
and its strength and fracture persistence are several times better than characteristics of the 
bone tissue and the glass-ceramic material (see Table 3). 
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 Titanium Bone Glass-ceramic 
Compressive strength (MPa)  100-230 1080 
Tensile strength, flexural strength* 
(MPa) 
240–680 200* 170–218* 
Elasticity modulus (GPa) 100–120 25 220 
Fracture persistence (MPa·m-1/2) ~40–100 2-12 2 
Table 3. Comparison of mechanical properties of titanium, bone and glass-ceramic BAS-0.  
The mechanically and chemically modified surface of the bioactive titanium by LASAK 
technology is able to induce the production of calcium-phosphate (apatite), and this compound 
arises from the interaction between the surface of the material and body fluid within hours to 
days. The chemical and crystallographical properties of this mineral are nearly identical with 
the bone apatite. Experimental studies with bioactive and bioinert titanium demonstrated that 
titanium with a bioactive surface better tolerates unfavourable conditions for osseointegration, 
as gaps between the implant and the bone (Strnad et al, 2003). Bioinert titanium allows 
penetration of fibrous tissue into the interface implant/bone, and  promotes instability or 
migration of implants towards the spinal canal in conditions requiring spondylosurgery. 
However, a firm interaction between the calcium-phosphate layer of the implant and the 
surrounding bone forms immediately after application if bioactive titanium with technological 
modification according to LASAK is used, which ultimately eliminates this risk.  
Strength parameters and bioactivity would be expected to improve conditions for 
osseointegration in the intervertebral space, as compared to implants generated from 
bioinert materials and glass-ceramic. Therefore, this type of material appears to be optimal 
for the development of a new implant for PLIF. Based on our experiences with the glass-
ceramic BAS-O, we designed a new implant model constructed from this material. Due to 
different properties of these two materials (glass-ceramic/biotitanium), we modified the 
shape of the implant, and we designed new application instrumentation. The basic model 
was the shape of skewed prism (4o) (20 mm long, 8 mm wide, with graduated high 6, 8 and 
10 mm). The implant was equipped with two pairs of projections or winglets (2 mm high) 
on the opposite sides of the prism. The compression and bending load of our original model 
for PLIF was virtually mathematically tested using computer technology in cooperation 
with ČVUT Prague. These tests showed that the shape of the skewed prism with winglets 
can theoretically ensure the restoration of the anatomy of the operated segment of lumbar 
spine without a risk of a plunge into the adjacent vertebral bodies both during compression 
and flexion and without a risk of its damage (Figure 6). 
Based on these mathematical analyses, we maintained the basic shape of the implant with 
the above mentioned parameters. The higher strength of the material allowed us to design 
simplified application instrumentation. We used a thread in the implant body instead of the 
Teflon-coated fork used in the implant BAS-O. Due to its strength, no opposite space 
dilatation was necessary before the application as a result of the bioactive titanium implant, 
and no risk of damage of the implant shape by metal loaders was detected. Therefore, the 
handling of the implant during an intervention is easy and safe. The shape of the implant 
ensured good restoration of the anatomy of the operated area (restoration of the interbody 
space and its stability) with minimal risk of implant plunge into the adjacent vertebral 
bodies, as demonstrated by imaging investigations. Other benefits of the new implant 
included higher strength and shape variability. 
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Fig. 6. Illustration of the mathematical testing of the implant model. 
 
Fig. 7. Implaspin in the intersomatic space of a cadaver by CT (2001). 
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We removed the whole motion segment with implants from cadavers after experimental 
operations, and we assessed their localization and the degree of their damage by X-ray and 
CT scans (Filip et al, 2001). Both investigations showed proper localization of the implants in 
the intervertebral spaces without any contact with the spinal canal or perforation of the 
winglets into the adjacent vertebral bodies (figure 7). 
Additionally, their shape and surface were not damaged by the new type of 
instrumentation. Therefore, we assumed that these findings would transfer from 
experimental studies into clinical practice. However, we were not able to verify the 
osseoconductive properties of the implant surface in the cadavers. A perfect contact was 
observed between the surrounding bone tissue resulting from the simple application in 
cadavers, which was a good precondition for supporting osseointegration in the interbody 
space via osteoblasts´ migration along its surface. Thus, we verified the osseoconductive 
properties of the BIO surface of the implant in an animal model (Strnad, 2008). The implant 
surface in the direct contact with newly produced bone tissue yielded the following values 
[BIC (%) = 48,5 ± 2,9, 66,0 ± 7,4 and 90,6± 7,0, respectively, two, five and twelve weeks after 
implantation].  
 
Fig. 8. Histological section of the interface of newly formed bone tissue on the BIO surface of 
the titanium implant twelve weeks after implantation. This figure illustrates the 
osseoconductive properties of the surface (optical microscope, toluidine blue staining, 
original magnification -  200x). 
2.6 Implaspin in clinical practice  
Encouraged by these experimental results, we began to use this type of implant in clinical 
practice in indications for PLIF instead of the glass-ceramic implant since 2002 (Figure 9).  
The operation technique PLIF was identical to the operation technique used in cadavers 
(Filip et al, 2010). For example, we decompressed the nervous structures through posterior 
median line approach, and we then radically removed the degenerated intervertebral disc 
under the control of the operation microscope. Afterwards, we removed the surfaces of the 
adjacent vertebral bodies, and we then inserted the bioactive titanium implant using the 
innovated instrumentation (Figure 10). Finally, we added transpedicular fixation of the 
whole segment (Synthes, Signus, Easy spine, etc.) (Figure 11). 
www.intechopen.com
 Low Back Pain Pathogenesis and Treatment 
 
212 
 
Fig. 9. Implant from bioactive titanium – Implaspin (2002). 
 
Fig. 10. Insertion of Implaspin into the interbody space. 
   
Fig. 11. Transpedicular application of screws (SIGNUS) 
To date, we have not observed any complications associated with the implant application into 
the interbody space. According to the postoperative scans, the implant was always placed in 
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the correct position with winglet penetration into the spongious tissue of the adjacent vertebral 
bodies. We have selected the size empirically according to the extent of osteochondrosis of the 
affected disc and the degenerative lesions of the surrounding tissues on scans (X-ray, CT, MRI) 
during the intervention. In the majority of cases, we used implants (8 or 10 mm high) with 
angle 4% to maintain lordosis in the lumbar area (Figure 12). 
 
Fig. 12. Fixation L4/5 (Implaspin plus transpedicular screws Signus). 
According to the experimental studies, tight contact with the surrounding bone tissue was 
necessary to activate the bioactivity of the surface. This contact was ensured by the shape of 
the implant and the winglets that penetrated into the spongious bone tissue of the adjacent 
vertebral bodies, and was the precondition for migration of the osteoblasts along the 
implant body resulting in the formation of a junction of the adjacent vertebral bodies by 
bone tissue without the need to sample bone grafts or to add supporting synthetic materials 
inside or around the implants. 
In 2002 to 2007, operations were performed on 57 patients using the bioactive implant 
Implaspin in the Neurosurgery Clinic of the Faculty Hospital in Ostrava and in the 
Neurosurgery Department of Tomáš Baťa´s Regional Hospital in Zlín. We assessed a 
population of 25 patients with follow-up examinations conducted two or more years 
following surgery, according to the clinical condition. The follow-ups were also based on the 
generally used score system ODI and imaging methods (X-ray, CT, MRI) that occurred 
three, six, twelve and 24 months after surgery. During the follow-ups, we examined the 
patients for signs of implant damage, instability of the operated segment, and signs of 
supposed osteoblastic activity of the bioactive surface of the implant on the scans. Results of 
the ODI questionnaire showed that with Implaspin, our success rate improved by 1 degree 
(59%–40%), or we stabilized the clinical condition of the majority of the patients long-term (2 
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and more years), which corresponds to results of other clinics using other implant types 
(Bessho et al, 1997; Brantigan et al 1993; Brayan et al, 2002; Bienik and Swiecki, 1991; 
Ciappetta et al, 1997; see Table 4). 
ODI score in our population [%] Mean [n] 25 FBSS [n] 9 IS [n] 6 DI [n] 10 
Before surgery 59 65 55 57 
3 months after surgery 42 46 40 40 
6 months after surgery 40 45 37 38 
12 months after surgery 41 45 39 39 
24 months after surgery 40 47 35 38 
Table 4. Mean Oswestry score values before surgery and at regular visits (FBSS – failed back 
surgery syndrome; IS – isthmic spondylolisthesis; DI – degenerative instability). 
The assessment of the implant position on scans (X-ray, CT, MRI) at postoperative visits 
demonstrated no signs of implant damage or implant migration out of the intersomatic 
space. These investigations have not yet shown any signs of instability of the operated 
segment (i.e., formation of new osteophytes, progression of hypertrophy of the articular 
facets, and migration of the implant at the site of application). We observed one severe 
complication in the population which was caused by an inaccurate application of the 
transpedicular screws. The wound healed in this patient, and the neurological findings 
stabilized after removal of the screws. The stabilization of the condition may be supported 
by the implant shape and the winglets which prevented instability even after the removal of 
the transpedicular screws. This finding was confirmed by the imaging investigations. Based 
on the clinical condition and the absence of instability signs on imaging investigations, we 
concluded that the formation of bone fusion was due to osteopblasts´ migration along the 
bioactive of Implaspin surface.  
2.7 Assessment of bioactivity of the implant using SPECT-CT 
During our investigations, we attempted to demonstrate the migration of bone cells along 
the surfaces of the glass-ceramic or biotitanium implants using imaging investigations. 
Unfortunately, standard CT or MRI were not able to provide this precise information. The 
CT scans were limited by screw artefacts, and the MRI scans were generally unable to detect 
changes in bone. In an attempt to resolve these problems, we utilized SPECT-CT, a method 
that provides up-to-date computed tomography (CT) and gamma camera (SPECT), to detect 
the activity of the osteoblasts on the body of the titanium implant applied into the interbody 
space. The computed tomography (CT) can precisely display the anatomic structure of the 
investigated tissue, and the gamma camera investigation (SPECT) can yield a functional 
view of the metabolic process in the patient´s body, but without its precise localization or 
other anatomical details. Thereby, the combination of these investigations provided more 
complete information on the precise place of the metabolic process as well as its dynamics. 
In our study, the metabolic process included the activity of the osteoblasts on the surface of 
the bioactive implant, as applied by the PLIF method. 
In 2009, we performed this type of investigation in four patients after surgery for the 
primary instability of the lower lumbar spine segment using the PLIF operation technique 
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with Implaspin. The study was conducted before the surgery as well as two and six months 
after the intervention, and we assessed the anatomical changes and metabolic activity at the 
location where the implants were applied by using the combined scans. The investigation 
provided preoperative signs of instability localized to the affected space in the area of the 
disc in all four patients. We detected a hyperintense signal at the operated segment two to 
three months after the surgery, which was a sign of osteoblast activity on the surface of the 
implant. We also observed a decrease of this activity (hypointense signal) six months after 
the surgery as well as a change on the surface of the implant using the combined CT scans.  
 
Fig. 13. Implants applied into the spaces L3/4 and L4/5 on SPECT CT. The figure shows the 
surface of the implant with the bone tissue (grey-black colour) and the titanium screw in the 
body of the L3 (white colour). 
 
Fig. 14. Implants on a SPECT-CT scan. The bone growth at the border of bone tissue (grey) 
and Implaspin (white) is visible in the space L4/5. 
www.intechopen.com
 Low Back Pain Pathogenesis and Treatment 
 
216 
According to our method, hypointensity signified the completion of the osteoblastic activity. 
The changes on the CT scans were completed by conducting a measurement using 
Haunsfield´s units (metal – about 2000 HU; bone tissue 100–300 HU), which provided 
evidence that the implant was overgrown by bone tissue. This kind of image detects the 
primary successful binding of the implant via activation of the osteoblasts by its specially 
adapted bioactive surface (figure 13 and 14).  Using this combined imaging technique in all 
four patients, we demonstrated the migration of bone cells along Implaspin wall and the 
formation of fusion without the addition of another material, such as autografts or TCP, six 
months after the surgery. Therefore, the successful fusion was indirectly confirmed using 
the SPECT-CT improving the postoperative clinical findings. 
3. Conclusion  
The development of both the material and the shapes of implants continues to progress. 
Currently, the primary focus of this development is to produce an implant that forms a firm 
fusion as soon as possible and to ensure the formation of new bone due to its material 
composition. The current implants for PLIF combine two separate components, including a 
solid cage shape and osseoconductive material (i.e., TCP, BMP) that ensures the activity of 
osteoblasts and the formation of the interbody fusion. To date, none of the materials for 
PLIF available on the market optimally meet both characteristics (see Table 5). 
Optimal parameters of the 
implant 
Metal 
(Titanium, 
steel) 
PEEK or 
+PEEK 
carbon 
fibres 
Glass-ceramic 
Resorbable 
implants - 
polylactides 
Bioactive 
titanium 
(LASAK 
Ltd.) 
1. Firm structural support 
(load resistance 
immediately after 
implantation) 
+ + +/- +/- + 
2. Osseoconductivity, 
bioactivity – ability to 
bind with a bone, support 
of fusion without addition 
of other material  
(bone, TCP, etc.) 
- - + - + 
3. Possibility of 
radiographic assessment 
of the bone fusion 
progression 
+ + + + + 
4. Biomechanical 
properties (elasticity 
modulus similar to bone) 
- + - +/- - 
Table 5. Parameters of the implant according to the type of material. 
During this investigation, our goal was to develop an implant that would combine both of 
these components in one unit, ultimately maintaining the strength and bioactive properties 
present in two-component implants. At the end of the 1990s, we were close to the development 
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of such material due to the implant BAS-0. However, the resistance of the glass-ceramic at the 
ultimate load provided a limitation that negatively influenced the shape and the application 
process, as described in chapters 2.3 and 2.4. However, due to these experiences, we and other 
technicians successfully designed an implant that meets our original conception. This implant 
is currently used in clinical practice, and experimental studies have confirmed its supposed 
properties. The combination of the implant’s strength and shape with bioactivity enables the 
smooth application and restoration of anatomy, thereby providing a perfect fixation of the 
operated segment and stimulating growth of osteoblasts and their migration along its surface. 
Our original implant Implaspin combines the osteoconductive and osteoplastic properties of 
the glass-ceramic with the strength of titanium, which was the aim of our research. Thanks to 
these properties, this implant represents a quality alternative to implants constructed from 
other materials dedicated to PLIF (see Table 5). 
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